Alcon (ALC) Launches Preservative-Free Drops for Dry Eye Relief
Zacks Investment Research | Jan 13, 2022 08:29PM ET
Alcon (NYSE:ALC) Inc. ALC recently announced an addition to its advanced portfolio of dry eye products with the European launch of Systane Complete Preservative-Free Lubricant Eye Drops, available in an easy-to-use, multi-dose bottle. This launch strengthens Alcon’s foothold in the large and fast-growing artificial tears market.
The launch of Systane Complete Preservative-Free expands Alcon’s multi-dose, preservative-free portfolio to include an all-in-one solution for patients with dry eye symptoms. The Systane Complete Preservative-Free joins the Systane Ultra Preservative-Free and the Systane Hydration Preservative-Free to offer a full range of multi-dose, preservative-free dry eye relief products for patients suffering from mild to chronic dry eye symptoms.
Starting in Europe, the Systane Complete Preservative-Free launch is anticipated to extend to the United States, Australia and other markets during 2022.
h3 More on the Product/h3The Systane Complete Preservative-Free formula hydrates and protects all layers of the tear film to deliver all-in-one dry eye relief with just one drop. Alcon’s proprietary formula utilizes intelligent moisture and lipid delivery to improve dispersion throughout the eye's surface, stabilizing the tear film. Its innovative nano-droplet technology provides fast-acting hydration, tear evaporation protection, and long-lasting relief.
The bottle’s closing tip system was built with patented PureFlow technology to ensure the safe delivery of the preservative-free artificial tear. Further, the bottle contains a one-way valve that eliminates the requirement for preservatives in the eye drops.
Per management, the Systane Complete Preservative-Free offers up to eight hours of relief for all major forms of dry eye. This new product will allow frequent users of artificial tears, or those with sensitive eyes, to manage their symptoms effectively and conveniently.
h3 Industry Prospects/h3
Apollo Endosurgery has outperformed its industry in the past year. APEN has gained 60.3% versus the industry’s 0.4% rise.
Patterson Companies, sporting a Zacks Rank #2, has a long-term earnings growth rate of 9.9%. The company surpassed earnings estimates in three of the trailing four quarters and missed in one, delivering an average surprise of 3.7%.
Patterson Companies has underperformed its industry over the past year. PDCO has declined 12.7% versus the industry’s 5.3% rise.
Get The News You Want
Infrastructure Stock Boom to Sweep America
A massive push to rebuild the crumbling U.S. infrastructure will soon be underway. It’s bipartisan, urgent, and inevitable. Trillions will be spent. Fortunes will be made.
The only question is “Will you get into the right stocks early when their growth potential is greatest?”
Zacks has released a Special Report to help you do just that, and today it’s free. Discover 5 special companies that look to gain the most from construction and repair to roads, bridges, and buildings, plus cargo hauling and energy transformation on an almost unimaginable scale.
Download FREE: How to Profit from Trillions on Spending for Infrastructure >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. To read this article on Zacks.com click here.
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.